Clinical

Dataset Information

0

CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population


ABSTRACT: The purpose of this study is to evaluate the performance of the SEPT9 gene methylation assay in Colorectal cancer (CRC) high-risk population in Chinese hospitals using the opportunistic screening method. The trial plans to evaluate a Chinese domestic SEPT9 assay kit produced by BioChain (Beijing) Science and Technology Corporation, who is a close partner of Epigenomics AG, the producer for Epi proColon 2.0 CE.

DISEASE(S): Other Cancers,Adenomatous Polyps,Colonic Polyps,Other Disease/injury,Adenomatous Polyp Of Colon,Colorectal Cancer,Colorectal Neoplasms,Polyps

PROVIDER: 2197424 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2012-07-12 | E-GEOD-39298 | biostudies-arrayexpress
2015-08-07 | PXD000700 | Pride
| 2249389 | ecrin-mdr-crc
2011-01-26 | E-GEOD-26854 | biostudies-arrayexpress
2023-11-08 | GSE161072 | GEO
2024-10-18 | PXD056927 | Pride
| 2123980 | ecrin-mdr-crc
2017-02-23 | GSE95204 | GEO
2016-04-13 | E-GEOD-80209 | biostudies-arrayexpress
2011-01-26 | GSE26854 | GEO